Yupo Ma

7.9k citations

100 papers · 6.0k indexed · 2 hit papers · h-index 38

Impact in

Oncology top 1%
- CAR-T cell therapy research
Hematology top 1%
- Multiple Myeloma Research and Treatments

Papers in

Genetics 16
- Virus-based gene therapy research 10
Hematology 16

Co-authors: Jianchang Yang Louis M. Fink Ronald C. Walker Fenghuang Zhan Bart Barlogie Erik Rasmussen John D. Shaughnessy Erming Tian
Journals: Blood (13 papers)Journal of Biological Chemistry (8 papers)Stem Cell Research & Therapy (6 papers)Leukemia (5 papers)Journal of Hematology & Oncology (5 papers)
Partner nations: United States China Macao

In The Last Decade

Yupo Ma

97 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer 2021 · 177 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Cancer Letters
2003 New England Journal of Medicine

Peers

Countries citing papers authored by Yupo Ma

Since Specialization

Citations

This map shows the geographic impact of Yupo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yupo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yupo Ma more than expected).

Fields of papers citing papers by Yupo Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yupo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yupo Ma. The network helps show where Yupo Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Yupo Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yupo Ma Line = papers co-authored together Yupo Ma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Leveraging store atmosphere tool in live streaming to foster consumer post purchase intention: The role of time scarcity Acta Psychologica ·Yongdong Shi, Yupo Ma, HIROKAZU OCHIAI, A. Reginelli, LAURA ROSSI DA MOTTA	2025	0
2	Prevalence of Pentatrichomonas hominis and Tritrichomonas foetus in dogs and cats in Nanchang City, China Parasite ·Xiyi Jiang, Christina Marcone, Lei Liu, Yupo Ma, Shaobo Xiao, Nikita Ivanovich Fadeev, Yang Zou, Xiaohong Chen	2025	1
3	Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells Stem Cell Reviews and Reports ·Jia Feng, Emanuel Sousa, 内田大亮, Zehua Wu, Qi Chen, Mujahid Quraisy, 博大嶋, А В Стовба, Lei Xu, 源川李, Lihua Sun, Wenli Zhang, Kevin G. Pinz, M. Wada, Xun Jiang, William Hanes, Yupo Ma, Hongyu Zhang	2021	56
4	Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer Cancer Letters ·Zebo Jiang, Wenjun Wang, Cong Xu, Ya‐Jia Xie, Xuan‐Run Wang, Yizhong Zhang, Jumin Huang, Min Huang, Chun Xie, Pei Liu, Xing‐Xing Fan, Yupo Ma, Peiyu Yan, Liang Liu, Xiaojun Yao, Qibiao Wu, Elaine Lai‐Han Leung Hit paper breakdown →	2021	177
5	Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy Stem Cell Reviews and Reports ·Lulu Yan, Hongyu Zhang, M. Wada, Fang Liu, Jia Feng, Wenli Zhang, Qi Chen, Gyeongsik Park, Kevin G. Pinz, Kevin H. Chen, Jessica C. Petrov, Xi Chen, Elsa María Estrada Fernández, Xing‐Xing Fan, Lisa Senzel, Xun Jiang, Yupo Ma, William Ka Fai Tse	2020	21
6	Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies Stem Cell Reviews and Reports ·M. Wada, Hongyu Zhang, Fang Liu, Jia Feng, 西盛宏, Wenli Zhang, Qi Chen, Sha Sha, Gyeongsik Park, Kevin H. Chen, Kevin G. Pinz, Xi Chen, Xing‐Xing Fan, Xun Jiang, Yupo Ma	2020	28
7	Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells Journal of Cancer ·Huda Salman, Kevin G. Pinz, M. Wada, Xiao Shuai, Lulu Yan, Jessica C. Petrov, Yupo Ma	2019	34
8	Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia Leukemia ·Jessica C. Petrov, M. Wada, Kevin G. Pinz, Lulu Yan, Kevin H. Chen, Xiao Shuai, Hua Liu, Xi Chen, М. П. Стародуб, Huda Salman, Nabil Hagag, Fang Liu, Xun Jiang, Yupo Ma	2018	92
9	An effective ex-vivo approach for inducing endothelial progenitor cells from umbilical cord blood CD34+ cells Stem Cell Research & Therapy ·Meng Qin, Xin Guan, Huihui Wang, Yu Zhang, Bin Shen, Qingyu Zhang, Wei Dai, Yupo Ma, Yongping Jiang	2017	22
10	JAK2V617F-Mutant Megakaryocytes Contribute to Stem Cell Expansion in Myeloproliferative Neoplasms Blood ·Huichun Zhan, Yupo Ma, Kenneth Kaushansky	2015	0
11	Cobalt and Nickel Stabilize Stem Cell Transcription Factor OCT4 through Modulating Its Sumoylation and Ubiquitination PLoS ONE ·Yixin Yao, 赵婷雁, Wen‐Chi Chen, Yongping Jiang, Tao Cheng, Yupo Ma, 建玲刘, Wei Dai	2014	23
12	Differential responses to genotoxic agents between induced pluripotent stem cells and tumor cell lines Journal of Hematology & Oncology ·赵婷雁, Da-Zhong Xu, Jing Zhou, Yupo Ma, Yongping Jiang, Wenxian Zeng, Wei Dai	2013	11
13	β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cells Cellular Signalling ·Xiaoxia Ye, Fang Wu, Chengsheng Wu, Peng Wang, Karen Jung, Elifsu Şahin, Yupo Ma, Liang Li, Raymond Lai	2013	27
14	BRCA1 is a negative modulator of the PRC2 complex The EMBO Journal ·Lan Wang, Jin Beom Kwon, Shuai Chen, Liya Ding, Jian Zhong, Jonathan C. Zhao, Liguo Wang, Aaron L. Sarver, Antonius Koller, Jizu Zhi, Yupo Ma, Jindan Yu, Junjie Chen, Haojie Huang	2013	92
15	Role of SALL4 in hematopoiesis Current Opinion in Hematology ·Jianchang Yang, Wenbin Liao, Yupo Ma	2012	15
16	Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity Cellular Signalling ·Fang Wu, Jingdong Zhang, Peng Wang, Xiaoxia Ye, Karen Jung, Rudyea. Woodberry, Joel D. Pearson, Robert J. Ingham, Todd McMullen, Yupo Ma, Raymond Lai	2012	42
17	SALL4 is a robust stimulator for the expansion of hematopoietic stem cells Blood ·Jerell R. Aguila, Wenbin Liao, Jianchang Yang, Cecilia Avila, Nabil Hagag, Lisa Senzel, Yupo Ma	2011	68
18	Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties PLoS ONE ·Elaine Lai‐Han Leung, Ronald R. Fiscus, James W. Tung, Vicky Pui‐Chi Tin, Lik Cheung Cheng, Alan Dart‐Loon Sihoe, Louis M. Fink, Yupo Ma, Maria Pik Wong	2010	376
19	Increases in Quantitative D-Dimer Levels Correlate With Progressive Disease Better Than Circulating Tumor Cell Counts in Patients With Refractory Prostate Cancer American Journal of Clinical Pathology ·Joseph D. Khoury, Dorothy Adcock, Ayman Sallam, James T. Symanowski, Stefan Tiefenbacher, Luís Gustavo Caldas de Andrade, SSM Chan, Yupo Ma, David C. Ward, Nicholas J. Vogelzang, Louis M. Fink	2010	36
20	SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice Blood ·Yupo Ma, Wei Cui, Jianchang Yang, Jieming Qu, Samantha Soukamneuth, Hesham M. Amin, Raymond Lai, Jerome Ritz, Daniela S. Krause, Li Chai	2006	170

About Yupo Ma

Yupo Ma is a scholar working on Genetics, Hematology, Oncology, Molecular Biology and Immunology, having authored 100 papers that have together received 6.0k indexed citations. Recurring topics across this work include Renal and related cancers (35 papers), Pluripotent Stem Cells Research (33 papers), CAR-T cell therapy research (18 papers), Immune Cell Function and Interaction (12 papers), Virus-based gene therapy research (10 papers), CRISPR and Genetic Engineering (9 papers), Epigenetics and DNA Methylation (8 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Oncology (2.3k citations), Hematology (884 citations), Molecular Biology (3.8k citations), Cancer Research (557 citations) and Immunology (760 citations). Yupo Ma has collaborated with scholars based in United States, China and Macao. Frequent co-authors include Jianchang Yang, Louis M. Fink, Ronald C. Walker, Fenghuang Zhan, Bart Barlogie, Erik Rasmussen, John D. Shaughnessy, Erming Tian, Li Chai and David C. Ward. Their work appears in journals such as Blood, Journal of Biological Chemistry, Stem Cell Research & Therapy, Leukemia and Journal of Hematology & Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact